Resmed (RSMDF) Asset Writedowns and Impairment (2009 - 2020)

Resmed has reported Asset Writedowns and Impairment for 10 years, with the latest figure at $9.1 million in Q1 2020.

• For the quarter ending Q1 2020, Asset Writedowns and Impairment rose 55.77% year-over-year to $9.1 million; the trailing twelve-month figure through Mar 2020 stood at $20.7 million (up 23.55% YoY), and the FY2019 full-year result was $15.0 million, up 29.45% from the prior year.
• Asset Writedowns and Impairment for Q1 2020 stood at $9.1 million, up from $2.8 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $9.1 million in Q1 2020, with the low at -$2.1 million in Q2 2016.
• Historically, Asset Writedowns and Impairment has averaged $2.9 million across 5 years, with a median of $1.7 million in 2018.
• Annual changes were most pronounced in 2017 — Asset Writedowns and Impairment plunged 81.5% — and 2018, when it soared 483.25%.
• Resmed's Asset Writedowns and Impairment stood at -$2.1 million in 2016, then jumped by 162.57% to $1.3 million in 2017, then slipped by 3.41% to $1.2 million in 2018, then jumped by 126.68% to $2.8 million in 2019, then jumped by 221.67% to $9.1 million in 2020.
• The last three Asset Writedowns and Impairment figures came in at $9.1 million (Q1 2020), $2.8 million (Q4 2019), and $2.6 million (Q3 2019), per Business Quant data.